Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Chen

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Malaria Journal|May 21, 2024
Population pharmacokinetics of primaquine and its metabolites in African malesPalang Chotsiri, Almahamoudou Mahamar, Halimatou Diawara, et al.
The American Journal of Tropical Medicine and Hygiene|May 28, 2015
Review of mass drug administration for malaria and its operational challengesGretchen Newby, Jimee Hwang, Kadiatou Koita, et al.
Malaria Journal|April 5, 2025
Asymptomatic malaria reservoirs are the last challenge in the elimination in CambodiaDyna Doum, David J McIver, Ingrid Chen, et al.
Clinical Pharmacology and Therapeutics|December 14, 2021
Mechanistic Modeling of Primaquine Pharmacokinetics, Gametocytocidal Activity, and Mosquito InfectivityPalang Chotsiri, Almahamoudou Mahamar, Richard M Hoglund, et al.
BMC Public Health|January 21, 2022
Effective management of district-level malaria control and elimination: implementing quality and participative process improvementsBruce Agins, Peter Case, Daniel Chandramohan, et al.
BMJ Open|March 27, 2024
Child Health and Infection with Low Density (CHILD) malaria: a protocol for a randomised controlled trial to assess the long-term health and socioeconomic impacts of testing and treating low-density malaria infection among children in TanzaniaSylvia Jebiwott, Nicolaus Gutapaka, Deborah Sumari, et al.
Malaria Journal|August 12, 2017
Barriers to routine G6PD testing prior to treatment with primaquineBenedikt Ley, Kamala Thriemer, Jessica Jaswal, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2019
<i>CYP2D6</i> Polymorphisms and the Safety and Gametocytocidal Activity of Single-Dose Primaquine for Plasmodium falciparumHelmi Pett, John Bradley, Joseph Okebe, et al.
The Journal of Infectious Diseases|January 18, 2018
Safety of Single-Dose Primaquine in G6PD-Deficient and G6PD-Normal Males in Mali Without Malaria: An Open-Label, Phase 1, Dose-Adjustment TrialIngrid Chen, Halimatou Diawara, Almahamoudou Mahamar, et al.
Malaria Journal|March 18, 2018
Low risk of recurrence following artesunate-Sulphadoxine-pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the SudanMuzamil Mahdi Abdel Hamid, Kamala Thriemer, Maha E Elobied, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Malaria Journal|May 21, 2024
Population pharmacokinetics of primaquine and its metabolites in African malesPalang Chotsiri, Almahamoudou Mahamar, Halimatou Diawara, et al.
The American Journal of Tropical Medicine and Hygiene|May 28, 2015
Review of mass drug administration for malaria and its operational challengesGretchen Newby, Jimee Hwang, Kadiatou Koita, et al.
Malaria Journal|April 5, 2025
Asymptomatic malaria reservoirs are the last challenge in the elimination in CambodiaDyna Doum, David J McIver, Ingrid Chen, et al.
Clinical Pharmacology and Therapeutics|December 14, 2021
Mechanistic Modeling of Primaquine Pharmacokinetics, Gametocytocidal Activity, and Mosquito InfectivityPalang Chotsiri, Almahamoudou Mahamar, Richard M Hoglund, et al.
BMC Public Health|January 21, 2022
Effective management of district-level malaria control and elimination: implementing quality and participative process improvementsBruce Agins, Peter Case, Daniel Chandramohan, et al.
BMJ Open|March 27, 2024
Child Health and Infection with Low Density (CHILD) malaria: a protocol for a randomised controlled trial to assess the long-term health and socioeconomic impacts of testing and treating low-density malaria infection among children in TanzaniaSylvia Jebiwott, Nicolaus Gutapaka, Deborah Sumari, et al.
Malaria Journal|August 12, 2017
Barriers to routine G6PD testing prior to treatment with primaquineBenedikt Ley, Kamala Thriemer, Jessica Jaswal, et al.
Antimicrobial Agents and Chemotherapy|August 7, 2019
<i>CYP2D6</i> Polymorphisms and the Safety and Gametocytocidal Activity of Single-Dose Primaquine for Plasmodium falciparumHelmi Pett, John Bradley, Joseph Okebe, et al.
The Journal of Infectious Diseases|January 18, 2018
Safety of Single-Dose Primaquine in G6PD-Deficient and G6PD-Normal Males in Mali Without Malaria: An Open-Label, Phase 1, Dose-Adjustment TrialIngrid Chen, Halimatou Diawara, Almahamoudou Mahamar, et al.
Malaria Journal|March 18, 2018
Low risk of recurrence following artesunate-Sulphadoxine-pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the SudanMuzamil Mahdi Abdel Hamid, Kamala Thriemer, Maha E Elobied, et al.
Pageof 5